Herpes simplex virus 1 (HSV-1) reactivation in critically ill COVID-19 patients: A brief narrative review

DR Giacobbe, S Di Bella, A Lovecchio, L Ball… - Infectious Diseases and …, 2022 - Springer
Systemic or pulmonary reactivations of herpes simplex virus 1 (HSV-1) have been reported
in critically ill patients with COVID-19, posing a dilemma for clinicians in terms of their …

Pattern-recognition receptors (PRRs) in SARS-CoV-2

A Isazadeh, JA Heris, P Shahabi, R Mohammadinasab… - Life Sciences, 2023 - Elsevier
Pattern recognition receptors (PRRs) are specific sensors that directly recognize various
molecules derived from viral or bacterial pathogens, senescent cells, damaged cells, and …

[HTML][HTML] Human metapneumovirus prevalence during 2019-2021 in Israel is influenced by the COVID-19 pandemic

M Stein, H Cohen, I Nemet, N Atari, L Kliker… - International Journal of …, 2022 - Elsevier
Objectives To compare infection rates and circulating subtypes of human metapneumovirus
(hMPV) before (2019-2020) and after the emergence of coronavirus disease 2019 (COVID …

The immunomodulatory role of cell-free approaches in SARS-coV-2-induced cytokine storm—A powerful therapeutic tool for COVID-19 patients

M Csobonyeiova, V Smolinska, S Harsanyi… - Biomedicines, 2023 - mdpi.com
Currently, there is still no effective and definitive cure for the coronavirus disease 2019
(COVID-19) caused by the infection of the novel highly contagious severe acute respiratory …

Lessons from SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 Infections: What We Know So Far

RT Alsafi - Canadian Journal of Infectious Diseases and …, 2022 - Wiley Online Library
Within past decades, human infections with emerging and reemerging zoonotic viral
pathogens have raised the eminent public health concern. Since November 2002, three …

Multi-level biological network analysis and drug repurposing based on leukocyte transcriptomics in severe COVID-19: in silico systems biology to precision medicine

P Sagulkoo, H Chuntakaruk, T Rungrotmongkol… - Journal of personalized …, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic causes many morbidity and mortality
cases. Despite several developed vaccines and antiviral therapies, some patients …

Inhibitors of SARS-CoV-2 main protease: Biological efficacy and toxicity aspects

J Viskupicova, P Rezbarikova, L Kovacikova… - Toxicology in Vitro, 2023 - Elsevier
The emergence of the highly contagious respiratory disease, COVID-19, caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a significant …

Mechanistic understanding of lung inflammation: recent advances and emerging techniques

C Keskinidou, AG Vassiliou, I Dimopoulou… - Journal of …, 2022 - Taylor & Francis
Acute respiratory distress syndrome (ARDS) is a life-threatening lung injury characterized by
an acute inflammatory response in the lung parenchyma. Hence, it is considered as the most …

Relative effectiveness of bivalent COVID-19 vaccine: a systematic review and meta-analysis

M Cheng, R Li, Z Weng, G Song - Frontiers in Medicine, 2024 - frontiersin.org
Objective The rapid development of COVID-19 bivalent vaccines (BVs) has encompassed
both the original virus strains and the variant strain. However, the effectiveness of BVs is …

Safety of multiple intravenous infusions of adipose-derived mesenchymal stem cells for hospitalized cases of COVID-19: a randomized controlled trial

C de Dios, R Vij, H Kim, H Park, D Chang - Frontiers in Medicine, 2023 - frontiersin.org
Objective The purpose of the study was to assess the safety of allogeneic, Hope Biosciences
Adipose Derived Mesenchymal Stem Cells (HB-adMSCs) for the treatment of hospitalized …